Zeo ScientifiX sets faculty for 3-day regenerative event
Zeo ScientifiX, Inc. (ZEOX) reported that it has announced the faculty and guest speaker lineup for its inaugural ZEO Xperience, a three-day immersive regenerative medicine educational event for healthcare professionals.
Rhea-AI Filing Summary
Zeo ScientifiX, Inc. (ZEOX) reported that it has announced the faculty and guest speaker lineup for its inaugural ZEO Xperience, a three-day immersive regenerative medicine educational event for healthcare professionals. The program will be held October 23–25, 2026 at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida, with multidisciplinary experts spanning clinical specialties, regulatory law, regenerative science, and healthcare business. The event extends the company’s physician-education platform, which also includes Master Classes, webinars, scientific programming, and clinical collaborations, and is intended to foster direct interaction and knowledge-sharing among attendees and faculty.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Event dates: October 23–25, 2026
Press release date: September 1, 2026
Event duration: Three days
3 metrics
Event dates
October 23–25, 2026
Scheduled dates of the inaugural ZEO Xperience regenerative medicine event
Press release date
September 1, 2026
Date ZEO ScientifiX announced the ZEO Xperience faculty lineup
Event duration
Three days
Length of the immersive ZEO Xperience educational program
Key Terms
regenerative medicine, regenerative biologics, clinical-stage biopharmaceutical company, regulatory landscape, +1 more
5 terms
regenerative medicine medical
"three days of regenerative medicine education, hands-on clinical training"
A field of medical treatments that aims to repair, replace or regenerate damaged tissues and organs using approaches such as cell or gene therapies, engineered tissues, and biologically active materials. It matters to investors because successful regenerative therapies can create entirely new, high-value markets and replace chronic treatments, offering large potential returns but also long development timelines, heavy regulation and high technical risk—like betting on a promising new technology that could either revolutionize care or fail in trials.
regenerative biologics medical
"focused on the research, development, and manufacturing of regenerative biologics"
clinical-stage biopharmaceutical company medical
"ZEO ScientifiX, Inc. ... is an SEC-reporting, clinical-stage biopharmaceutical company"
A clinical-stage biopharmaceutical company develops drugs or medical therapies that are being tested in people in formal clinical trials but do not yet have any approved, marketed products. For investors, these firms behave like prototype makers: their value depends heavily on trial results and regulatory decisions, so they can swing widely on a single study, consume cash while testing, and offer either large upside if trials succeed or big downside if they fail.
regulatory landscape regulatory
"including ... the current regulatory landscape, current clinical best practices"
forward-looking statements regulatory
"Certain statements contained in this press release should be considered forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What did ZEOX announce in the September 1, 2026 Form 8-K?
ZEO ScientifiX, Inc. announced the multidisciplinary faculty and guest speaker lineup for its inaugural ZEO Xperience, a three-day regenerative medicine educational event for healthcare professionals in Fort Lauderdale, Florida, scheduled for October 23–25, 2026.
When and where will ZEO ScientifiX’s ZEO Xperience event take place?
The ZEO Xperience is scheduled for October 23–25, 2026 at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida, and is described as a three-day immersive regenerative medicine education and hands-on clinical training event for healthcare professionals.
What is the focus of the ZEO Xperience announced by ZEOX?
The ZEO Xperience focuses on regenerative medicine education, covering the science and manufacturing of biologics, the regulatory landscape, clinical best practices across multiple specialties, and practice implementation, with both classroom-based sessions and hands-on clinical training.
How does the ZEO Xperience relate to ZEO ScientifiX’s broader strategy?
The ZEO Xperience builds on ZEO ScientifiX’s expanding physician-education platform, which includes Master Classes, webinars, scientific programming, clinical collaborations, and national educational partnerships aimed at supporting responsible advancement of regenerative medicine.
Is attendance at ZEO ScientifiX’s ZEO Xperience limited?
Yes. The company states that attendance is intentionally limited to support meaningful interaction between attendees, faculty, exhibitors, and participating healthcare professionals, with both full-event and select single-day attendance options available.
AI-generated analysis. How Rhea-AI works. Not financial advice.
